TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
UPSC | Exam ScheduleExam Mentor
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
News Columns | Kashmir AngleJammu JournalInside the CapitalHimachal CallingHill View
Don't Miss
Advertisement

No magic bullets: AIIMS chief

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

Remdesivir: No magic bullet. No study in the world has shown it reduces mortality. It is to be used in moderately ill Covid patients who are hospitalised with very low oxygen and high lung damage. Mild cases improve with paracetamol, hydration and multivitamins.

Advertisement

Steroids: Useful in moderate to severely ill, but must be given at the right time because mortality is higher if steroids are given before a patient’s oxygen levels fall too low.

Advertisement

Plasma: ICMR studies have shown it’s not useful

Tocilizumab: Will be needed in less than 2% Covid patients who are severely ill and in whom steroids and anticoagulants have stopped working.

Advertisement

Advertisement
Show comments
Advertisement